Nevertheless, in the APP/PS1 model, the reduction of the number of parvalbumin expressing neurons in the CA1/2 hippocampal sublayer and of calretinin-immunoreactive neurons in DG is at the same order of magnitude as in post mortem hippocampal tissue from AD subjects (Takahashi et al., 2010). The gene discussed is PSEN1; the disease is Alzheimer disease.